BSE - Delayed Quote INR

Ambuja Cements Limited (AMBUJACEM.BO)

Compare
548.25 -0.45 (-0.08%)
At close: December 27 at 3:29:01 PM GMT+5:30
Loading Chart for AMBUJACEM.BO
DELL
  • Previous Close 548.70
  • Open 545.20
  • Bid 546.75 x --
  • Ask 558.00 x --
  • Day's Range 545.20 - 553.80
  • 52 Week Range 452.90 - 706.85
  • Volume 26,045
  • Avg. Volume 119,248
  • Market Cap (intraday) 1.35T
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 41.85
  • EPS (TTM) 13.10
  • Earnings Date Jan 29, 2025 - Feb 3, 2025
  • Forward Dividend & Yield 2.00 (0.36%)
  • Ex-Dividend Date Jun 14, 2024
  • 1y Target Est 647.78

Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

www.ambujacement.com

3,548

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AMBUJACEM.BO

View More

Performance Overview: AMBUJACEM.BO

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMBUJACEM.BO
5.56%
S&P BSE SENSEX
8.94%

1-Year Return

AMBUJACEM.BO
8.86%
S&P BSE SENSEX
10.32%

3-Year Return

AMBUJACEM.BO
52.71%
S&P BSE SENSEX
37.77%

5-Year Return

AMBUJACEM.BO
216.08%
S&P BSE SENSEX
91.19%

Compare To: AMBUJACEM.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMBUJACEM.BO

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    1.35T

  • Enterprise Value

    1.24T

  • Trailing P/E

    41.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.94

  • Price/Book (mrq)

    2.68

  • Enterprise Value/Revenue

    3.85

  • Enterprise Value/EBITDA

    17.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.05%

  • Return on Assets (ttm)

    3.82%

  • Return on Equity (ttm)

    7.73%

  • Revenue (ttm)

    328.5B

  • Net Income Avi to Common (ttm)

    29.74B

  • Diluted EPS (ttm)

    13.10

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    88.03B

  • Total Debt/Equity (mrq)

    1.30%

  • Levered Free Cash Flow (ttm)

    -72.18B

Research Analysis: AMBUJACEM.BO

View More

People Also Watch